If you "look at the pattern of dots there, you will see that of all the studies that have now been done, most of the dots fall on the right-hand side," he noted. "This means that there is an increased risk that Paxil causes birth defects."
"What I want you to look at here ... is the consistency," he told the jury. "The dots are all falling on the right-hand side of the line, which shows an increased risk."
"When GlaxoSmithKline added all this up," Healy said, "you see the dot at the bottom, that is statistically significant."
"They say there is no chance that Paxil is not causing these birth defects. Chance is gone. It is causing the birth defects," he told the jury.
With the chart on cardiac birth defects, "again, you see the patterns of dots are mostly on the right," Healy pointed out.
"What you see here at the end," he said, "shows you a 1.5-fold increase in risk."
This "comes from their Web site," he stated, "I have had no part in trying to generate these data at all."
While testifying, Healy discussed several of the studies in Glaxo's analysis, including the abstract for a presentation given at a conference in 2001, referred to as Unfred, which also had an author named Chambers. The full paper on the study, with Chambers as the author, had never been published but the data was in Glaxo's database.
Next Page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
